[Cite as http://purl.org/au-research/grants/nhmrc/1059660]
Prof Michael Berk
Brief description Concordant with the NHMRC priorities, this fellowship will principally focus on the development of novel therapies for mood disorders. We have pilot data that the amino acid, N acetyl cysteine reduces symptoms in unipolar and bipolar disorder and schizophrenia. We will further delineate the spectrum of efficacy, mechanisms of action and tolerability profile of this and related agents. We also will study risk factors and pathways for the development of depression, to develop public health strategies.
Funding Amount $AUD 863,413.61
Funding Scheme Research Fellowships